Role of endogenous norepinephrine in cardiac inotropic effects of nucleosides.
D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000032:analysis / Q000378:metabolism; D009638:Norepinephrine / Q000032:analysis / Q000502:physiology*; D009705:Nucleosides / Q000494:pharmacology*; D010477:Perfusion; D011817:Rabbits; D013268:Stimulation, Chemical; D014439:Tyramine / Q000494:pharmacology; D014529:Uridine / Q000494:pharmacology*
D009705:Nucleosides; D004295:Dihydroxyphenylalanine; D014529:Uridine; D009638:Norepinephrine; D014439:Tyramine